Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 484-490-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
- Objective of study:
- toxicokinetics
Test guideline
- Qualifier:
- no guideline followed
Results and discussion
Applicant's summary and conclusion
- Conclusions:
- The water solubility of R507-2 is very low (<7 x 10E-5 g/l). Since in general a substances needs to be dissolved before it can be taken up from the gastro intestinal tract, it is unlikely that R507-2 will show a high systemic exposure after oral administration. Although small amount of particles might be taken up by pinocytosis, this absorption will be limited due to the absence of R507-2 particles in the nanometer size range. The absorption will furthermore be reduced by the relatively large molecular weight (553) of this substance limiting passage through biological membranes. In addition, ionization of R507-2 will impair the uptake since the compounds need to pass the lipid membranes in the gastrointestinal wall. The log Pow of R507-2 is not defined, but the solubility in n-octanol is low. Therefore, uptake by micellular solubilisation is considered low. For risk assessment purposes the oral absorption of R507-2 is set at 10%. The result of the toxicity studies do not provide reasons to deviate from this proposed oral absorbtion factor.
In the gastro-intestinal tract the diazo-bond might be reduced to form two primary amines (2). Absorbed R507-2 might undergo further metabolism (incl. aromatic hydroxylation and reduction of azo-bond) followed by conjugation (2). In view of the low water solubility of R507-2 (<7 x 10E-5 g/l) a low potantial for distribution through the human body is anticipated. Distribution into cells will be limited due to high molecular weight (553g/mol) of R507-2. Because of the reduced molecular weight after reduction of the diazo-bond, the conjugates will either be excreted via the bile or the urine.
Based on the particle size of R507-2 <100µm, which have a potential to be inhaled, are present. Particles wil predominantly settle in the nasopharyngeal region (particles with aerodynamic >1-5µm). The low water solubility of R507-2 indicates a potential for clearance by coughing/sneezing (nasopharyngeal region) or via the mucocillary mechanism (tracheobronchial region). Accumulation might occur in the alveolar region where phagocytosis is the main route for absorption and clearance. As the logPow is not defined for this substance, no assessment on the potential for absorption directly across the respiratory tract epithelium is possible. As it is unlikely that R507-2 will be absorbed significantly after inhalation via the lungs, for risk assessment purposes the inhalation absorption of R507-2 is set at 10% as a worst case assumption.
R507-2 being a solid with low water solubility (<1mg/L) has no real potential for dermal absorption. Since the logPow of this substance could not be determined , it can not be assessed whether any anticipated lipophylic character will influence dermal absorption. Although the criteria for 10% dermal absorption of R507-2 is proposed for risk assessment purposes based on its solid form, its low solubility in water and in n-octanol (<1.1 x 10E-3 g/l), and its high molecular weight. The results of the toxicity studies do not provide reasons to deviate from this proposed dermal absorption factor.
Based on the present available data, no additional conclusions can be drawn on the distribution, metabolism and excretion of R507-2 after dermal and inhalatory absorption.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.